Is Thymosin Beta-4 FDA approved?
No. This profile records Thymosin Beta-4 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE FULL-SPECTRUM HEALER
TB4, Tβ4, Thymosin β-4
Thymosin Beta-4 is a 43-amino-acid peptide that your body naturally produces to orchestrate healing. It promotes blood vessel formation, reduces scarring (fibrosis), and protects tissues from damage. It's particularly valued for heart recovery after injury and reducing inflammation throughout the body. TB-500 is a fragment of this full-length peptide.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Thymosin Beta-4 as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 300 mcg daily for 2 weeks (Ac-SDKP fragment).
Schedule: daily. Cycle: 2 weeks on, 6 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Ac-SDKP fragment suppresses TGF-β1 signaling to reduce scarring and fibrosis
AGES fragment protects heart cells and promotes cardiomyocyte survival after injury
Tβ4(1-15) fragment increases protective Bcl-2/Bax ratio and activates survival pathways
Promotes formation of new blood vessels to support tissue repair
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.